Detail akcie PerkinElmer Inc online

Business Summary: Revvity, Inc. is a provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. The Company has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.
Financial Summary: BRIEF: For the three months ended 30 March 2025, Revvity Inc revenues increased 2% to $664.8M. Net income before extraordinary items increased 45% to $41.7M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Change in fair value of financial securi increase from $806K (expense) to $3.1M (income), Interest expense decrease of 6% to $23M (expense).